Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07136766) titled 'An 18-week Study to Evaluate a Test Product With a Marketed Prescription Product' on Aug. 14.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).
Primary Sponsor: Good Molecules, LLC
Condition:
Hyperpigmentation
Intervention:
Drug: Facial Toner
Recruitment Status: Recruiting
Phase: Phase 3
Date of First Enrollment: September 10, 2025
Target Sample Size: 40
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07136766
Publishe...